BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32726790)

  • 1. Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal Cell Carcinoma with Advanced Clinicopathological Features.
    Horie K; Kawakami K; Fujita Y; Matsuda Y; Arai T; Suzui N; Miyazaki T; Koie T; Mizutani K; Ito M
    Oncology; 2020; 98(10):734-742. PubMed ID: 32726790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer.
    Kawakami K; Fujita Y; Matsuda Y; Arai T; Horie K; Kameyama K; Kato T; Masunaga K; Kasuya Y; Tanaka M; Mizutani K; Deguchi T; Ito M
    BMC Cancer; 2017 May; 17(1):316. PubMed ID: 28476099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
    Dalpiaz O; Pichler M; Mrsic E; Reitz D; Krieger D; Venturino L; Bezan A; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC
    J Clin Pathol; 2015 Jul; 68(7):547-51. PubMed ID: 25862811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma.
    Hofbauer SL; Stangl KI; de Martino M; Lucca I; Haitel A; Shariat SF; Klatte T
    Br J Cancer; 2014 Oct; 111(8):1526-31. PubMed ID: 25117808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum gamma glutamyl-transferase is a sensitive but unspecific marker of metastatic renal cell carcinoma.
    Simic T; Dragicevic D; Savic-Radojevic A; Cimbaljevic S; Tulic C; Mimic-Oka J
    Int J Urol; 2007 Apr; 14(4):289-93. PubMed ID: 17470155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma.
    Ramankulov A; Lein M; Kristiansen G; Meyer HA; Loening SA; Jung K
    J Cancer Res Clin Oncol; 2007 Sep; 133(9):643-52. PubMed ID: 17479289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma.
    Priolo C; Khabibullin D; Reznik E; Filippakis H; Ogórek B; Kavanagh TR; Nijmeh J; Herbert ZT; Asara JM; Kwiatkowski DJ; Wu CL; Henske EP
    Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6274-E6282. PubMed ID: 29891694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Gamma-Glutamyltransferase Is Associated with Cancer-Specific Survival and Recurrence-Free Survival of Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
    Luo C; Xu B; Fan Y; Yu W; Zhang Q; Jin J
    Biomed Res Int; 2017; 2017():3142926. PubMed ID: 28168196
    [No Abstract]   [Full Text] [Related]  

  • 10. Exosomal microRNA-1 and MYO15A as a target for therapy and diagnosis in renal cell carcinoma.
    Yoshino H; Tatarano S; Tamai M; Tsuruda M; Iizasa S; Arima J; Kawakami I; Fukumoto W; Kawahara I; Li G; Sakaguchi T; Inoguchi S; Yamada Y; Enokida H
    Biochem Biophys Res Commun; 2022 Nov; 630():71-76. PubMed ID: 36150242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer.
    Grimm C; Hofstetter G; Aust S; Mutz-Dehbalaie I; Bruch M; Heinze G; Rahhal-Schupp J; Reinthaller A; Concin N; Polterauer S
    Br J Cancer; 2013 Aug; 109(3):610-4. PubMed ID: 23921280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial lectin affinity chromatography demonstrates altered asparagine-linked sugar chain structures of gamma-glutamyltransferase in human renal cell carcinoma.
    Yoshida K; Sumi S; Honda M; Hosoya Y; Yano M; Arai K; Ueda Y
    J Chromatogr B Biomed Appl; 1995 Oct; 672(1):45-51. PubMed ID: 8590936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Serum γ-Glutamyltransferase on Overall Survival in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy.
    Takemura K; Yuasa T; Inamura K; Amori G; Koga F; Board PG; Yonese J
    Target Oncol; 2020 Jun; 15(3):347-356. PubMed ID: 32474759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of serum γ-glutamyltransferase in patients with advanced urothelial carcinoma.
    Takemura K; Fukushima H; Ito M; Kataoka M; Nakanishi Y; Sakamoto K; Suzuki H; Tobisu KI; Koga F
    Urol Oncol; 2019 Feb; 37(2):108-115. PubMed ID: 30478012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells.
    Lin H; Pan JC; Zhang FM; Huang B; Chen X; Zhuang JT; Wang H; Mo CQ; Wang DH; Qiu SP
    Urol Oncol; 2015 Apr; 33(4):168.e9-16. PubMed ID: 25618297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of gamma-glutamyltransferase in patients with resectable esophageal squamous cell carcinoma.
    Yang F; Zhang S; Yang H; Luo K; Wen J; Hu Y; Hu R; Huang Q; Chen J; Fu J
    Dis Esophagus; 2015 Jul; 28(5):496-504. PubMed ID: 24766310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of hepatic parameters in renal cell carcinoma (RCC) by interleukin-6 (IL-6)?
    Wechsel HW; Feil G; Lahme S; Zumbragel A; Petri E; Bichler KH
    Anticancer Res; 1999; 19(4A):2577-81. PubMed ID: 10470198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
    Wechsel HW; Petri E; Bichler KH; Feil G
    Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of serum gamma glutamyl transpeptidase levels in low stage renal cell carcinoma.
    Speights VO; Rappaport E; Beissner RS
    Am J Clin Pathol; 1990 Apr; 93(4):560-2. PubMed ID: 1969711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.
    Rausch S; Schollenberger D; Hennenlotter J; Stühler V; Kruck S; Stenzl A; Bedke J
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):153-163. PubMed ID: 30368665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.